1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Immunologic Deficiency Syndromes in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goodman, MG | 1 |
| Gupta, S | 1 |
| Rosenthale, ME | 1 |
| Capetola, RJ | 1 |
| Bell, SC | 1 |
| Weigle, WO | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Protein kinase C independent restoration of specific immune responsiveness in common variable immunodeficiency.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Alkaloids; Antibody Formation; Antigens, CD; C | 1991 |